The DOI matches its Crossref record; 56 of the 58 references it cites were found in a registry or an index.
Novel Oncogenic PDGFRA Mutations in Pediatric High-Grade Gliomas
Open accessPublished version of a preprint
Abstract
The outcome for children with high-grade gliomas (HGG) remains dismal, with a 2-year survival rate of only 10% to 30%. Diffuse intrinsic pontine glioma (DIPG) comprise a subset of HGG that arise in the brainstem almost exclusively in children. Genome-wide analyses of copy number imbalances previously showed that platelet-derived growth factor receptor α (PDGFRA) is the most frequent target of focal amplification in pediatric HGGs, including DIPGs. To determine whether PDGFRA is also targeted by more subtle mutations missed by copy number analysis, we sequenced all PDGFRA coding exons from a cohort of pediatric HGGs. Somatic-activating mutations were identified in 14.4% (13 of 90) of nonbrainstem pediatric HGGs and 4.7% (2 of 43) of DIPGs, including missense mutations and in-frame deletions and insertions not previously described. Forty percent of tumors with mutation showed concurrent amplification, whereas 60% carried heterozygous mutations. Six different mutations impacting different domains all resulted in ligand-independent receptor activation that was blocked by small molecule inhibitors of PDGFR. Expression of mutants in p53-null primary mouse astrocytes conferred a proliferative advantage in vitro and generated HGGs in vivo with complete penetrance when implanted into brain. The gene expression signatures of these murine HGGs reflected the spectrum of human diffuse HGGs. PDGFRA intragenic deletion of exons 8 and 9 were previously shown in adult HGG, but were not detected in 83 nonbrainstem pediatric HGG and 57 DIPGs. Thus, a distinct spectrum of mutations confers constitutive receptor activation and oncogenic activity to PDGFRα in childhood HGG.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“suggesting that, unlike WT PDGFRA, PDGFRAD842V does not require H3.3K27M to drive tumorigenesis in vivo”
From H3.3K27M Cooperates with Trp53 Loss and PDGFRA Gain in Mouse Embryonic Neural Progenitor Cells to Induce Invasive High-Grade Gliomas (2017) · cites this paper as Paugh et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,656
Adjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., et al. (1998) · Science · doi:10.1126/science.279.5350.577 · Cited by 4,487
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
Barbie, D. A., Tamayo, P., Boehm, J. S., Kim, S. Y., Moody, S. E., Dunn, I. F., Schinzel, A. C., Sandy, P., Meylan, E., Scholl, C., et al. (2009) · Nature · doi:10.1038/nature08460 · Cited by 3,922
PHILLIPS, H. S., Kharbanda, S., Chen, R., Forrest, W. F., Soriano, R. H., Wu, T. D., Misra, A., Nigro, J. M., Colman, H., Soroceanu, L., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.02.019 · Cited by 3,197
Cahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Schwartzentruber, J., Korshunov, A., Liu, X.-Y., Jones, D. T. W., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A. M., Quang, D.-A. K., Tönjes, M., et al. (2012) · Nature · doi:10.1038/nature10833 · Cited by 2,631
Cited by
Sorted by citations
Items 101–200 of 235
Genomic Profiling Identified Novel Prognostic Biomarkers in Chinese Midline Glioma Patients
Li, H., Shan, C., Wu, S., Cheng, B., Fan, C., Cai, L., Chen, Y., Shi, Y., Liu, K., Shao, Y. W., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.607429 · Cited by 28
Mathias, T. J., Natarajan, K., Shukla, S., Doshi, K. A., Singh, Z. N., Ambudkar, S. V., & Baer, M. R. (2015) · Investigational New Drugs · doi:10.1007/s10637-015-0205-y · Cited by 28
Yang, Y., Koh, Y. W., Sari, I. N., Jun, N., Lee, S., Phi, L. T., Kim, K. S., Wijaya, Y. T., Lee, S. H., Baek, M. J., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31926 · Cited by 28
Killick-Cole, C. L., Singleton, W., Bienemann, A. S., Asby, D. J., Wyatt, M. J., Boulter, L. J., Barua, N. U., & Gill, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176855 · Cited by 24
Hu, W., Duan, H., Zhong, S., Zeng, J., & Mou, Y. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03258-1 · Cited by 25
JUN and PDGFRA as Crucial Candidate Genes for Childhood Autism Spectrum Disorder
Li, H., Wang, X., Hu, C., Li, H., Xu, Z., Lei, P., Luo, X., & Hao, Y. (2022) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2022.800079 · Cited by 25
Oncohistones and disrupted development in pediatric-type diffuse high-grade glioma
Ocasio, J. K., Budd, K. M., Roach, J. T., Andrews, J. M., & Baker, S. J. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10105-2 · Cited by 27
Self-citationMislocalisation of Activated Receptor Tyrosine Kinases – Challenges for Cancer Therapy
Schmidt‐Arras, D., & Böhmer, F. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.06.002 · Cited by 23
Carvalho, D. M., Mackay, A. G., Bjerke, L. M., Grundy, R. G., Lopes, M. C., Reis, R. M., & Jones, C. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-23 · Cited by 23
Self-citationPreclinical therapeutic targets in diffuse midline glioma
Meel, M. H., Kaspers, G. J. L., & Hulleman, E. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.06.001 · Cited by 23
Molecular alterations in pediatric brainstem gliomas
Porkholm, M., Raunio, A., Vainionpää, R., Salonen, T., Hernesniemi, J. A., Valanne, L. K., Satopää, J., Karppinen, A., Oinas, M., Tynninen, O., et al. (2017) · Pediatric Blood & Cancer · doi:10.1002/pbc.26751 · Cited by 22
Sturm, D., & Filbin, M. G. (2018) · Seminars in Neurology · doi:10.1055/s-0038-1635106 · Cited by 22
Tumor-Associated Microenvironment of Adult Gliomas: A Review
Nunno, V. D., Franceschi, E., Tosoni, A., Gatto, L., Bartolini, S., & Brandes, A. A. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.891543 · Cited by 22
The therapeutic potential of targeting the PI3K pathway in pediatric brain tumors
Rogers, H. A., Estranero, J. G., Gudka, K., & Grundy, R. G. (2016) · Oncotarget · doi:10.18632/oncotarget.13781 · Cited by 21
H3G34-Mutant Gliomas—A Review of Molecular Pathogenesis and Therapeutic Options
Nguyen, A. V. P., Soto, J. M., Gonzalez, S.-M. C., Murillo, J., Trumble, E. R., Shan, F. Y., & Huang, J. H. (2023) · Biomedicines · doi:10.3390/biomedicines11072002 · Cited by 22
Rahban, M., Joushi, S., Bashiri, H., Saso, L., & Sheibani, V. (2024) · Frontiers in Chemistry · doi:10.3389/fchem.2023.1325214 · Cited by 21
Tinkle, C. L., Broniscer, A., Chiang, J., Campagne, O., Huang, J., Orr, B. A., Li, X., Patay, Z. J., Zhang, J., Baker, S. J., et al. (2021) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdab179 · Cited by 20
Self-citationDiffuse Intrinsic Pontine Gliomas
Bredlau, A. L., & Korones, D. N. (2014) · Advances in cancer research · doi:10.1016/b978-0-12-800249-0.00006-8 · Cited by 19
Cardona, H. J., Somasundaram, A., Crabtree, D., Gadd, S., & Becher, O. J. (2021) · Brain and Behavior · doi:10.1002/brb3.2332 · Cited by 17
Germline MUTYH mutations and high‐grade gliomas: Novel evidence for a potential association
Bedics, G., Kotmayer, L., Zajta, E., Hegyi, L. L., Brückner, E. Á., Rajnai, H., Reiniger, L., Bödör, C., Garami, M., & Scheich, B. (2022) · Genes Chromosomes and Cancer · doi:10.1002/gcc.23054 · Cited by 17
Sheikh, S. R., Patel, N., & Recinos, V. (2024) · World Neurosurgery · doi:10.1016/j.wneu.2024.06.163 · Cited by 18
Molecular Basis of Pediatric Brain Tumors
Κλώνου, Α., Piperi, C., Gargalionis, A. N., & Papavassiliou, A. G. (2017) · NeuroMolecular Medicine · doi:10.1007/s12017-017-8455-9 · Cited by 17
Malignant Gliomas as Second Neoplasms in Pediatric Cancer Survivors: Neuropathological Study
Iżycka‐Świeszewska, E., Bień, E., Stefanowicz, J., Szurowska, E., Szutowicz-Zielińska, E., Koczkowska, M., Sigorski, D., Kloc, W., Rogowski, W., & Adamkiewicz-Drożyńska, E. (2018) · BioMed Research International · doi:10.1155/2018/4596812 · Cited by 17
Nonnenbroich, L. F., Bouchal, S. M., Millesi, E., Rechberger, J. S., Khatua, S., & Daniels, D. J. (2024) · Cells · doi:10.3390/cells13131122 · Cited by 18
Chromatin remodeling defects in pediatric brain tumors
Κλώνου, Α., Spiliotakopoulou, D., Themistocleous, M. S., Piperi, C., & Papavassiliou, A. G. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.04.08 · Cited by 16
Advanced Pediatric Diffuse Pontine Glioma Murine Models Pave the Way towards Precision Medicine
Chen, Z., Peng, P., Zhang, X., Mania-Farnell, B. L., Xi, G., & Wan, F. (2021) · Cancers · doi:10.3390/cancers13051114 · Cited by 19
Facing CAR T Cell Challenges on the Deadliest Paediatric Brain Tumours
Ferreras, C., Fernández, L., Villa, L. C., Ibáñez-Navarro, M., Martín-Cortázar, C., Esteban‐Rodríguez, I., Saceda-Gutierrez, J. M., & Pérez‐Martínez, A. (2021) · Cells · doi:10.3390/cells10112940 · Cited by 15
Huchedé, P., Leblond, P., & Castets, M. (2022) · Biomedicines · doi:10.3390/biomedicines10061311 · Cited by 19
Photodynamic therapy for malignant brain tumors in children and young adolescents
Chiba, K., Aihara, Y., Oda, Y., Fukui, A., Tsuzuki, S., Saito, T., Nitta, M., Muragaki, Y., & Kawamata, T. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.957267 · Cited by 15
Therapeutically targeting the unique disease landscape of pediatric high-grade gliomas
Fernando, D., Ahmed, A. U., & Williams, B. R. G. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1347694 · Cited by 15
Kolekar, P. S., Balagopal, V., Dong, L., Liu, Y., Foy, S. G., Tran, Q., Mulder, H. L., Huskey, A. L. W., Plyler, E. M., Liang, Z., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-1063 · Cited by 17
REST upregulates gremlin to modulate diffuse intrinsic pontine glioma vasculature
Shaik, S., Kennis, B. A., Maegawa, S., Schadler, K., Yanwen, Y., Callegari, K., Lulla, R. R., Goldman, S., Nazarian, J., Rajaram, V., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.23750 · Cited by 15
The 100 most-cited articles about diffuse intrinsic pontine glioma: a bibliometric analysis
Lu, V. M., Power, E. A., Kerezoudis, P., & Daniels, D. J. (2019) · Child s Nervous System · doi:10.1007/s00381-019-04254-5 · Cited by 15
Liu, G., Qiu, Y., Zhang, P., Chen, Z., Chen, S., Huang, W., Wang, B., Yu, X., & Guo, D. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091762 · Cited by 14
The Oncogenesis of Glial Cells in Diffuse Gliomas and Clinical Opportunities
Zhuang, Q., Yang, H., & Mao, Y. Q. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00953-3 · Cited by 16
CRISPR-engineered genome editing for the next generation neurological disease modeling
Feng, W., Liu, H., & Kawauchi, D. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.05.019 · Cited by 15
Sharma, M., Barravecchia, I., Teis, R., Cruz, J., Mumby, R. A., Ziemke, E. K., Espinoza, C. E., Krishnamoorthy, V., Magnuson, B., Ljungman, M. E., et al. (2023) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0026 · Cited by 12
A review of recently described genetic alterations in central nervous system tumors
Lucas, C. G., Solomon, D. A., & Perry, A. (2019) · Human Pathology · doi:10.1016/j.humpath.2019.10.009 · Cited by 12
Histone Variant H3.3: A versatile H3 variant in health and in disease
Xiong, C., Wen, Z., & Li, G. (2016) · Science China Life Sciences · doi:10.1007/s11427-016-5006-9 · Cited by 12
Sheikh, S. R., Recinos, V., Thompson, E. M., Mangum, R., Wright, M. L., Gampel, B. H., & Patel, N. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1504440 · Cited by 12
Improving Diagnostic and Therapeutic Outcomes in Pediatric Brain Tumors
Grob, S. T., & Levy, J. M. M. (2017) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-017-0299-3 · Cited by 10
Kenny, C., McDonagh, N., Lázaro, A., O’Meara, E., Klinger, R. W., O’Connor, D. P., Roche, F. M., Hokamp, K., & O’Sullivan, M. J. (2017) · The Journal of Pathology · doi:10.1002/path.5020 · Cited by 10
Emerging Therapeutic Strategies for Diffuse Intrinsic Pontine Glioma: A Systematic Review
Farrukh, S., Habib, S., Rafaqat, A., Sarfraz, Z., Sarfraz, A., Sarfraz, M., Robles‐Velasco, K., Félix, M., & Chérrez-Ojeda, I. (2023) · Healthcare · doi:10.3390/healthcare11040559 · Cited by 10
Arunachalam, S., Szlachta, K. A., Brady, S. W., Ma, X., Ju, B., Shaner, B., Mulder, H. L., Easton, J. B., Raphael, B. J., Myers, M. A., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01381-0 · Cited by 9
Self-citationHamada, T., Akahane, T., Yokoyama, S., Higa, N., Kirishima, M., Matsuo, K., Shimokawa, M., Yoshimoto, K., & Tanimoto, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-05391-9 · Cited by 9
Faisal, S. M., Yadav, M., Gibson, G. R., Klinestiver, A. T., Sorenson, R. M., Cantor, E., Ghishan, M., Prensner, J. R., Franson, A. T., Ginn, K. F., et al. (2025) · Cancers · doi:10.3390/cancers17132221 · Cited by 8
Pereira, R., Mackay, A. G., Grabovska, Y., Bradley, A., Bloom, T., Nicoll, J. A. R., Boche, D., Procter, J., Maybury, M. K., Schagen, J., et al. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-1256 · Cited by 8
Self-citationCarvalho, D. M., Temelso, S., Mackay, A. G., Pemberton, H. N., Rogers, R. F., Kessler, K., Izquierdo, E., Bjerke, L. M., Salom, J. F., Clarke, M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.29.424674 · Cited by 10
Self-citationAdvanced Pediatric Diffuse Pontine Glioma Animal Models Pave the Way Towards Precision MedicinePreprint
Chen, Z., Peng, P., Zhang, X., Mania-Farnell, B. L., Xi, G., & Wan, F. (2021) · Preprints.org · doi:10.20944/preprints202101.0337.v1 · Cited by 8
Receptor-driven invasion profiles in diffuse intrinsic pontine glioma
Karki, A., Berlow, N., Kim, J.-A., Hulleman, E., Liu, Q., Michalek, J. E., & Keller, C. (2021) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdab039 · Cited by 7
How to treat histone 3 altered gliomas: molecular landscape and therapeutic developments
Nunno, V. D., Franceschi, E., Gatto, L., Tosoni, A., Bartolini, S., & Brandes, A. A. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2023.2163385 · Cited by 7
de Villenfagne, L., Sablon, A., & Demoulin, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-57859-5 · Cited by 6
Advances in glioma models using in vivo electroporation to highjack neurodevelopmental processes
Zhang, L., & Bordey, A. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188951 · Cited by 7
Pediatric Glioma Models Provide Insights into Tumor Development and Future Therapeutic Strategies
Foss, A., & Pathania, M. (2023) · Developmental Neuroscience · doi:10.1159/000531040 · Cited by 8
Rechberger, J. S., Bouchal, S. M., Power, E. A., Nonnenbroich, L. F., Nesvick, C. L., & Daniels, D. J. (2023) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2023.2277232 · Cited by 5
PDGFRA gene, maternal binge drinking and obstructive heart defects
Tang, X., Eberhart, J. K., Cleves, M. A., Li, J., Li, M., Macleod, S. L., Nembhard, W. N., & Hobbs, C. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-29160-9 · Cited by 5
Mascarenhas, L., Ogawa, C., Laetsch, T. W., Weigel, B. J., Bishop, M. W., Krystal, J. I., Borinstein, S. C., Slotkin, E. K., Muscal, J. A., Hingorani, P., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.3658 · Cited by 5
Aberrant histone modifications in pediatric brain tumors
Hamanishi, E. T., Dang, D., & Venneti, S. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1587157 · Cited by 4
Disrupting PDGFRA-driven immune evasion in glioma: vaccine-based strategies on the horizon
Zhang, X., Li, X., Cui, R., Yu, X., Zhang, Z., Luo, Z., Chen, G., & Lin, S. H. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1666612 · Cited by 4
Upton, D. H., Liu, J., George, S. M., Valvi, S., Ung, C., Rayner, B. S., Gopalakrishnan, A., Pandher, R., Khan, A., Venkat, P., et al. (2025) · Neuro-Oncology · doi:10.1093/neuonc/noaf035 · Cited by 4
Liu, C., Kuang, S., Huang, T., Wu, J., Zhang, L., & Gong, X. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14730 · Cited by 4
Snape, T. J., & Warr, T. J. (2014) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2014.12.003 · Cited by 4
Histone Lysine-to-Methionine Mutation as Anticancer Drug Target
Yang, J., Qiu, Q., & Chen, L. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-8104-5_7 · Cited by 4
In the beginning: PDGFA and the genesis of GBM
Blough, M. D., Kumar, M., Bose, P., & Cairncross, J. G. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab004 · Cited by 3
PDGFB:APOBEC3C fusion in congenital diffuse high-grade glioma of the brainstem
Norris, G. A., Willard, N., Donson, A. M., Gaskell, A., Milgrom, S. A., O’Neill, B. R., Nijmeh, H., Haag, M. M., Gilani, A., Foreman, N. K., et al. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac112 · Cited by 3
Insights into the molecular roles of FOXR2 in the pathology of primary pediatric brain tumors
Gharbaran, R. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104188 · Cited by 3
Kaneva, K., Yeo, K. K., Hawes, D., Ji, J., Biegel, J. A., Nelson, M. D., Blüml, S., Krieger, M. D., & Erdreich‐Epstein, A. (2019) · JCO Precision Oncology · doi:10.1200/po.18.00138 · Cited by 3
Diffuse Intrinsic Pontine Glioma
Valvi, S., & Gottardo, N. G. (2018) · InTech eBooks · doi:10.5772/intechopen.78578 · Cited by 3
Skinner, K., Koga, T., Miki, S., Gruener, R. F., Grigore, F., Torii, E. H., Seelig, D. M., Suzuki, Y., Kawauchi, D., Lin, B., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.24.528982 · Cited by 3
Self-citationCruz, F. S. D., Fox, E., DuBois, S. G., Friedman, G. K., Croop, J. M., Kim, A., Morgenstern, D. A., Balis, F. M., Macy, M. E., Pressey, J. G., et al. (2025) · Pediatric Blood & Cancer · doi:10.1002/pbc.31692 · Cited by 2
Genetic alterations in paediatric high grade astrocytomas
Rakopoulos, P., & Hawkins, C. E. (2014) · Diagnostic histopathology · doi:10.1016/j.mpdhp.2014.01.003 · Cited by 2
Yoshida, K., CHAMBERS, J. K., & Uchida, K. (2024) · Veterinary Pathology · doi:10.1177/03009858241241793 · Cited by 2
PDGFRA in paediatric high-grade glioma – target or distraction?
Le, N., Chen, J., Ekert, P. G., Brown, L. M., & Manoharan, N. (2025) · Neoplasia · doi:10.1016/j.neo.2025.101231 · Cited by 2
Pediatric Brain Tumors – High-Grade Glioma
Mueller, S., & Karajannis, M. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-37101-8.00126-0 · Cited by 2
Vanan, M., Mehta, V., & Eisenstat, D. D. (2015) · Springer eBooks · doi:10.1007/978-1-4939-1541-5_10 · Cited by 2
CAR-T cells for H3K27-altered diffuse midline gliomas: where do we stand?
Power, E. A., Millesi, E., Rechberger, J. S., & Daniels, D. J. (2024) · Immunotherapy · doi:10.1080/1750743x.2024.2373043 · Cited by 2
The molecular oncology of bilateral high-grade thalamic astrocytomas in children
Goodarzi, A., Garza, N., Lechpammer, M., Anthony, R., & Zwienenberg, M. (2019) · Child s Nervous System · doi:10.1007/s00381-019-04372-0 · Cited by 1
Lambrou, G. Ι., Poulou, M., Γιαννίκου, Κ., Themistocleous, M. S., Zaravinos, A., & Braoudaki, M. (2021) · Cancers · doi:10.3390/cancers13215491 · Cited by 1
Fischer, T. T., Maaß, K. K., Schoof, M., Puranachot, P., Sievers, P., Montigel, S. H., Fluhr, T. L., Damaty, A. E., Seitz, A., Harrabi, S., et al. (2025) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaf110 · Cited by 1
Emerging interventional treatments in the management of pediatric brain tumors
Shatara, M., Ho, W. S., Roland, J. L., & Limbrick, D. D. (2025) · Advances in cancer research · doi:10.1016/bs.acr.2025.09.004 · Cited by 1
Diffuse Midline Gliomas: Clinical, Diagnostic, and Therapeutic Perspectives
Bihari, S., Yang, D., Mukherji, D., & Haggiagi, A. M. (2026) · Biomedicines · doi:10.3390/biomedicines14040934 · Cited by 1
Recent perspectives of molecular aberrations in pediatric high-grade glioma
Li, Z., Sun, Q., & Shi, Y. (2020) · Minerva Pediatrics · doi:10.23736/s0026-4946.17.04823-x · Cited by 1
Genomic Heterogeneity of Aggressive Pediatric and Adult Diffuse Astrocytomas
Pierson, C. R., & Thomas, D. (2021) · Molecular pathology library · doi:10.1007/978-3-030-69170-7_9 · Cited by 1
Population pharmacokinetics of crenolanib in children and young adults with brain tumors
Bisbee, C., Campagne, O., Gajjar, A. J., Tinkle, C. L., & Stewart, C. F. (2022) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-022-04412-8 · Cited by 1
Pediatric High-Grade Gliomas and DIPG
Becher, O. J., Barton, K. L., Halvorson, K. G., & McLendon, R. E. (2014) · Molecular pathology library · doi:10.1007/978-1-4939-1830-0_7 · Cited by 1
Sarkar, C., Purkait, S., Pathak, P., & Jha, P. (2017) · Current cancer research · doi:10.1007/978-3-319-56820-1_10 · Cited by 1
The dark matter of diffuse intrinsic pontine gliomas: an update
Grill, J., Debily, M.-A., Varlet, P., Plessier, A., Dret, L. L., Beccaria, K., Puget, S., & Castel, D. (2018) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2019.1560262 · Cited by 1
Diffuse Intrinsic Pontine Glioma: Translation of Genomic Knowledge to Clinical Practice
hou, T. Z., Khan, S. A., Firestein, R., Downie, P., & Cain, J. E. (2019) · OBM Neurobiology · doi:10.21926/obm.neurobiol.1901022 · Cited by 1
He, C., Xu, K., Zhu, X., Dunphy, P. S., Gudenas, B. L., Lin, W., Twarog, N. R., Hover, L. D., Kwon, C.-H., Kasper, L. H., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.06.407973 · Cited by 1
Self-citationCancer Immunotherapy Using AIRE Conditioning of the Tumor EpitopeomePreprint
Vile, R. G., Pulido, J. S., Chen, A., Kendall, B., Tonne, J. M., Metko, M. M., Thompson, J., Sangsuwannukul, T., Yerovi, M. C., Díaz, R. M., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-5411393/v1 · Cited by 1
Targeting the PDGF signaling pathway in tumor
Heldin, C. (2013)
Misuraca, K., Diaz, A., Baker, S. J., & Becher, O. J. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou268.12
Self-citation- Self-citation
Au, K. (2015) · TSpace (University of Toronto)
Chemotherapy of Pediatric High-Grade Gliomas
Upadhyaya, S. A., & Broniscer, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812100-9.00044-9
Self-citationLoveson, K. F., & Fillmore, H. L. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.17.386706
Investigating the Role of H3.3K27M during Cellular Transformation and Differentiation.
Rakopoulos, P. (2020) · TSpace (University of Toronto)
Molecular Stratification of Adult and Pediatric High Grade Gliomas
Yang, Y., Dai, H., & Lopez, G. Y. (2021) · Molecular pathology library · doi:10.1007/978-3-030-69170-7_8
Metadata
- Authors
- Paugh, B. S., Zhu, X., Qu, C., Endersby, R., Diaz, A. K., Zhang, J., Bax, D. A., Carvalho, D., Reis, R. M., Onar-Thomas, A., Broniscer, A., Wetmore, C., Zhang, J., Jones, C., Ellison, D. W., & Baker, S. J.
- Affiliations
- St. Jude Children's Research Hospital (US)
- Authors' Affiliations: Departments of 1Developmental Neurobiology, 2Computational Biology, 3Biostatistics, 4Oncology, and 5Pathology, St. Jude Children's Research Hospital; 6Interdisciplinary Biomedical Science Program, University of Tennessee Health Sciences Center, Memphis, Tennessee; 7Telethon Institute for Child Health Research, Centre for Child Health Research, The University of Western Australia, Perth, Australia; 8Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom; and 9Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil
- Corresponding author
- Baker, Suzanne J.
- ORCID
- Venue
- Cancer Research
- Published
- 2013-10-14
- Volume
- 73
- Issue
- 20
- Pages
- 6219-6229
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- PMC
- PMC3800209
- OpenAlex
- W2124839835
- Cited by
- 235
- References
- 58
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 17 · 2023: 14 · 2022: 23 · 2021: 25 · 2020: 14 · 2019: 14 · 2018: 22 · 2017: 26 · 2016: 17 · 2015: 14 · 2014: 23 · 2013: 3
- FWCI
- 9.34
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Funders
- V Foundation for Cancer Research
- Cure Starts Now Foundation
- American Lebanese Syrian Associated Charities
- Arog Pharmaceuticals
- Brain Tumour Charity
- National Institutes of Health
- National Cancer Institute (R01CA135554, P01CA096832, P30CA021765)
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal Tumor Research and Treatment
- Keywords
- PDGFRA mutation, pediatric high-grade glioma, diffuse intrinsic pontine glioma, somatic activating mutations, ligand-independent receptor activation, PDGFR inhibitors, oncogenic receptor tyrosine kinase, exon deletion, brainstem glioma
- MeSH terms
- Adolescent, Animals, Brain Neoplasms, Child, Child, Preschool, Glioma, Humans, Mutation, Receptor, Platelet-Derived Growth Factor alpha, Gene Expression Profiling, Mice, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
